1. JAK/STAT Signaling Stem Cell/Wnt NF-κB Vitamin D Related/Nuclear Receptor Anti-infection
  2. STAT NF-κB Estrogen Receptor/ERR Bacterial
  3. Saikosaponin D

サイコサポニンD  (Synonyms: Saikosaponin D)

製品番号: HY-N0250 純度: 99.81%
COA 取扱説明書 Technical Support

Saikosaponin D is a triterpene saponin isolated from Bupleurum, with anti-inflammatory, anti-bacterial, anti-tumor, and anti-allergic activities; Saikosaponin D inhibits selectin, STAT3 and NF-kB and activates estrogen receptor-β.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 20874-52-6

容量 価格(税別) 在庫状況 数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 103 在庫あり
Solution
10 mM * 1 mL in DMSO USD 103 在庫あり
Solid
1 mg $28 在庫あり
5 mg $60 在庫あり
10 mg $90 在庫あり
25 mg $180 在庫あり
50 mg $290 在庫あり
100 mg $520 在庫あり
200 mg   お問い合わせ  
500 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 10 publication(s) in Google Scholar

Other Forms of Saikosaponin D:

Top Publications Citing Use of Products

    Saikosaponin D purchased from MedChemExpress. Usage Cited in: Drug Des Devel Ther. 2021 Nov 23;15:4741-4757.  [Abstract]

    Cell viability of BMMs (bone marrow-derived macrophages) was evaluated by CCK-8 at 48, 96 h treated with Saikosaponin D (0.5, 1, 2, 4, 8, 16 μM).

    Saikosaponin D purchased from MedChemExpress. Usage Cited in: Drug Des Devel Ther. 2021 Nov 23;15:4741-4757.  [Abstract]

    The role of Saikosaponin D (SSD) (0.5, 1 μM) in osteoclast formation in a dose-dependent manner. BMMs stimulated by RANKL (50 ng/mL) were treated with or without various concentrations of SSD for 7 days. After fixing, the cells subjected to TRAP staining.

    Saikosaponin D purchased from MedChemExpress. Usage Cited in: Drug Des Devel Ther. 2021 Nov 23;15:4741-4757.  [Abstract]

    mRNA expression profile of OMG (osteoclast marker genes) (time-dependent). RT-qPCR (real-time quantitative PCR) was performed on total RNA extracted from cells stimulated by RANKL (50 ng/mL) and treated with 2 μM Saikosaponin D (SSD) for the indicated time points during the 5 day osteoclast culture.

    Saikosaponin D purchased from MedChemExpress. Usage Cited in: Drug Des Devel Ther. 2021 Nov 23;15:4741-4757.  [Abstract]

    BMMs were treated without or with various concentrations of SSD (0.5, 1 and 2 μmol/L) for 1 h and then were treated with RANKL (50 ng/mL) for 15 min. Total proteins extracted from BMMs were probed for protein levels using immunoblot analyses.

    Saikosaponin D purchased from MedChemExpress. Usage Cited in: Drug Des Devel Ther. 2021 Nov 23;15:4741-4757.  [Abstract]

    H&E staining and TRAP staining of calvaria from the high-dose Saikosaponin D (SSD) (4 mg/kg) group, low-dose SSD (2 mg/kg) group, LPS group, and sham group.

    STAT アイソフォーム固有の製品をすべて表示:

    NF-κB アイソフォーム固有の製品をすべて表示:

    Estrogen Receptor/ERR アイソフォーム固有の製品をすべて表示:

    • 生物活性

    • プロトコル

    • 純度とドキュメンテーション

    • 参考文献

    • カスタマーレビュー

    製品説明

    Saikosaponin D is a triterpene saponin isolated from Bupleurum, with anti-inflammatory, anti-bacterial, anti-tumor, and anti-allergic activities; Saikosaponin D inhibits selectin, STAT3 and NF-kB and activates estrogen receptor-β.

    IC50 & Target[2][3]

    STAT3

     

    NF-κB

     

    ERβ

     

    Cellular Effect
    Cell Line Type Value Description References
    A549 IC50
    30.82 3
    Compound: 9
    Cytotoxicity against human A549 cells assessed as induction of cell death incubated for 2 days by MTT assay
    Cytotoxicity against human A549 cells assessed as induction of cell death incubated for 2 days by MTT assay
    [PMID: 26259802]
    A549 IC50
    30.82 3
    Compound: 9
    Cytotoxicity against human A549 cells assessed as induction of cell death incubated for 2 days by MTT assay
    Cytotoxicity against human A549 cells assessed as induction of cell death incubated for 2 days by MTT assay
    [PMID: 26259802]
    Bcap37 IC50
    10.67 3
    Compound: 9
    Cytotoxicity against human Bcap37 cells assessed as induction of cell death incubated for 2 days by MTT assay
    Cytotoxicity against human Bcap37 cells assessed as induction of cell death incubated for 2 days by MTT assay
    [PMID: 26259802]
    Bcap37 IC50
    10.67 3
    Compound: 9
    Cytotoxicity against human Bcap37 cells assessed as induction of cell death incubated for 2 days by MTT assay
    Cytotoxicity against human Bcap37 cells assessed as induction of cell death incubated for 2 days by MTT assay
    [PMID: 26259802]
    HeLa IC50
    10 3
    Compound: 26
    Antiproliferative activity against human HeLa cells
    Antiproliferative activity against human HeLa cells
    [PMID: 32030976]
    HeLa IC50
    10 3
    Compound: 26
    Antiproliferative activity against human HeLa cells
    Antiproliferative activity against human HeLa cells
    [PMID: 32030976]
    Hep 3B2 IC50
    9.61 3
    Compound: 9
    Cytotoxicity against human Hep3B cells assessed as induction of cell death incubated for 2 days by MTT assay
    Cytotoxicity against human Hep3B cells assessed as induction of cell death incubated for 2 days by MTT assay
    [PMID: 26259802]
    Hep 3B2 IC50
    9.61 3
    Compound: 9
    Cytotoxicity against human Hep3B cells assessed as induction of cell death incubated for 2 days by MTT assay
    Cytotoxicity against human Hep3B cells assessed as induction of cell death incubated for 2 days by MTT assay
    [PMID: 26259802]
    HepG2 IC50
    4.88 3
    Compound: 9
    Cytotoxicity against human HepG2 cells assessed as induction of cell death incubated for 2 days by MTT assay
    Cytotoxicity against human HepG2 cells assessed as induction of cell death incubated for 2 days by MTT assay
    [PMID: 26259802]
    HepG2 IC50
    4.88 3
    Compound: 9
    Cytotoxicity against human HepG2 cells assessed as induction of cell death incubated for 2 days by MTT assay
    Cytotoxicity against human HepG2 cells assessed as induction of cell death incubated for 2 days by MTT assay
    [PMID: 26259802]
    MCF7 IC50
    7.68 3
    Compound: 9
    Cytotoxicity against human MCF7 cells assessed as induction of cell death incubated for 2 days by MTT assay
    Cytotoxicity against human MCF7 cells assessed as induction of cell death incubated for 2 days by MTT assay
    [PMID: 26259802]
    MCF7 IC50
    7.68 3
    Compound: 9
    Cytotoxicity against human MCF7 cells assessed as induction of cell death incubated for 2 days by MTT assay
    Cytotoxicity against human MCF7 cells assessed as induction of cell death incubated for 2 days by MTT assay
    [PMID: 26259802]
    体外実験

    Saikosaponin D (Compound 3) is a triterpene saponin, which inhibits E-selectin, L-selectin and P-selectin binding to THP-1 cells, with IC50s of 1.8 μM, 3.0 μM and 4.3 μM, and such effects are not due to cytotoxic action. Saikosaponin D (1, 5, 10 μM) dose-dependently inhibits the THP-1 adhesion to the HUVECs monolayer activated by TNF-α. Saikosaponin D (30 μM) also inhibits the expression of P-selectin ligand (CD162) in THP-1 cells[1]. Saikosaponin D (5 μM) suppresses the proliferation of HSC-T6 cells induced by H2O2 treatment, reduces the expression levels of α-SMA, TGF-β1, Hyp, COL1 and TIMP-1, and increases MMP-1 expressioon, thus inhibiting H2O2-induced excessive extracellular matrix (ECM) formation, with similar effects to estradiol (E2), and these effects are blocked by ER antagonists. Saikosaponin D also inhibits oxidative stress-induced ROS generation and down reduates MAPK signaling pathway, and the inhibition is also suppressed by ER antagonists[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    体内実験

    Saikosaponin D (2 mg/kg/day, i.p.) shows a protective effect on overdose of acetaminophen (APAP)-induced liver injury of mice. Saikosaponin D affects APAP metabolism, increases GSH levels but does not alter PPARα activation. Saikosaponin D (2 mg/kg/day, i.p.) also suppresses APAP-induced increases in the expression of STAT3 target genes and pro-inflammatory cytokines and inhibits APAP-induced activation of STAT3 and NF-kB[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    分子量

    780.98

    分子式

    C42H68O13

    CAS 番号
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    CC1(C)CC[C@]2(CO3)[C@H](O)C[C@@]4(C)[C@]([C@]5([H])C=C[C@]43[C@]2([H])C1)(C)CC[C@@]([C@]5(C)CC6)([H])[C@@](CO)(C)[C@H]6O[C@@](O[C@H](C)[C@@H]7O)([H])[C@H](O)[C@H]7O[C@@]8([H])[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O8

    Structure Classification
    Initial Source
    輸送条件

    Room temperature in continental US; may vary elsewhere.

    保管条件
    Powder -20°C 3 years
      4°C 2 years
    In solvent -80°C 6 months
      -20°C 1 month
    溶剤 & 溶解度
    体外: 

    DMSO : 50 mg/mL (64.02 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    H2O : < 0.1 mg/mL (insoluble)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 1.2804 mL 6.4022 mL 12.8044 mL
    5 mM 0.2561 mL 1.2804 mL 2.5609 mL
    10 mM 0.1280 mL 0.6402 mL 1.2804 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始)

    C1

    ×
    体積 (開始)

    V1

    =
    濃度 (終了)

    C2

    ×
    体積 (終了)

    V2

    体内:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.5 mg/mL (3.20 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% Corn Oil

      Solubility: ≥ 2.5 mg/mL (3.20 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    純度とドキュメンテーション

    純度: 99.81%

    参考文献
    細胞実験
    [1]

    Cell viability is assessed by morphology and by reduction of the tetrazolium salt (MTT). Briefly, the THP-1 cells (2 × 105 cells/well) and various concentrations of compounds 1-4 (including Saikosaponin D) are added to the 96-well plates, incubated for 48 h at 37°C, and 5 µL of MTT solution (5 mg/mL in PBS) is added to each well of the 96-well plates. After incubation for 4 h at 37°C, the absorbance is measured at 540 nm using a microplate reader with the reference absorbance at 650 nm[1].

    MedChemExpress (MCE) はこれらの方法の精度を確認していません。 こちらは参照専用です。

    動物実験
    [2]

    Mice[2]
    Male 6- to 7-week-old C57BL6 mice are randomly divided into four groups, vehicle/control, Saikosaponin D (SSd)/control, vehicle/APAP, and SSd/APAP, and killed 4 h or 24 h after single APAP injection. For overdose of acetaminophen (APAP) injection, a typical single dose of 200 mg/kg/day is used. Saikosaponin D, 2 mg/kg once daily is used as the dosing regimen. Saikosaponin D powder is dissolved in a saline solution supplemented with 0.1% Tween 20 and is administered by intraperitoneal injection at a dose of 2 mg/kg/day once daily for five days. Saline solution containing 0.1% Tween 20 without Saikosaponin D is administered as a vehicle. APAP is dissolved in warm saline solution (20 mg/mL) and is injected intraperitoneally 30 minutes after the last Saikosaponin D injection. Saline is injected to mice in the control groups[2].

    MedChemExpress (MCE) はこれらの方法の精度を確認していません。 こちらは参照専用です。

    参考文献

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 1.2804 mL 6.4022 mL 12.8044 mL 32.0111 mL
    5 mM 0.2561 mL 1.2804 mL 2.5609 mL 6.4022 mL
    10 mM 0.1280 mL 0.6402 mL 1.2804 mL 3.2011 mL
    15 mM 0.0854 mL 0.4268 mL 0.8536 mL 2.1341 mL
    20 mM 0.0640 mL 0.3201 mL 0.6402 mL 1.6006 mL
    25 mM 0.0512 mL 0.2561 mL 0.5122 mL 1.2804 mL
    30 mM 0.0427 mL 0.2134 mL 0.4268 mL 1.0670 mL
    40 mM 0.0320 mL 0.1601 mL 0.3201 mL 0.8003 mL
    50 mM 0.0256 mL 0.1280 mL 0.2561 mL 0.6402 mL
    60 mM 0.0213 mL 0.1067 mL 0.2134 mL 0.5335 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質量   濃度   体積   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    最近チェックした製品:

    オンラインお問い合わせ

    Your information is safe with us. * Required Fields.

    製品名

     

    カスタマ需要量 *

    お名前 *

     

    タイトル

    メールアドレス *

     

    電話番号 *

    デパートメント

     

    組纖名 *

    市区町村

    都道府県

    国或いは地域 *

         

    必ず会社名を記載ください。個人への返信は行いません。

    備考

    バルクお問い合わせ

    Inquiry Information

    製品名:
    Saikosaponin D
    製品番号:
    HY-N0250
    数量:
    MCE 日本正規代理店: